EQ - Latest News
Equillium, Inc. (EQ), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $83.5M. Beta to the broader market is 1.92.
The article list below shows the most recent EQ headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent EQ Headlines
Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
globenewswire.com - Oct 6, 2026
New preclinical data further characterizes EQ504's coordinated effects across epithelial and immune compartments in intestinal inflammation New precli
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
globenewswire.com - Oct 5, 2026
On track to initiate dosing by early November 2026; topline Phase 1 proof-of-mechanism data anticipated approximately six months following study initi
Equillium Announces Poster Presentations at the 7th International AHR Conference
globenewswire.com - Sep 29, 2026
New preclinical data further characterize EQ504's effects on epithelial barrier repair and immune regulation New preclinical data further characterize
Equillium Eyes Q4 Phase I Start for Ulcerative Colitis Drug EQ504
defenseworld.net - Sep 28, 2026
Equillium (NASDAQ: EQ) Chief Scientific Officer Stephen Connelly outlined the company's plans to advance its lead programs, including an oral aryl hyd
Equillium Eyes Q4 Phase I Start for Ulcerative Colitis Drug EQ504
marketbeat.com - Sep 27, 2026
Equillium NASDAQ: EQ Chief Scientific Officer Stephen Connelly outlined the company's plans to advance its lead programs, including an oral aryl hydro
How News Affects EQ Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track EQ's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked EQ news questions
- What is the latest EQ news headline?
- The most recent EQ headline (Oct 6, 2026) is "Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the EQ news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What EQ news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual EQ options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.